Femasys to exhibit at CFAS Annual Meeting

Femasys announces that the Company will be exhibiting at the Canadian Fertility and Andrology Society’s 70th Annual Meeting, to be held September 12-14, 2024 at The Westin Bayshore, Vancouver, British Columbia. The Company will be exhibiting at Booth #S26. Kathy-Lee Sepsick, Femasys Founder and CEO commented, “This is an important opportunity to connect with practitioners whose patients and clients would benefit from our suite of products. The conference comes at a particularly opportune moment as we recently announced the Canadian approval of FemVue MINI, our eco-friendly version of our solution for fallopian tube assessment. We continue to advance solutions to improve women’s reproductive health worldwide and look forward to demonstrating our portfolio of infertility products, including FemVue MINI and FemaSeed, our next generation artificial insemination product to potential customers.”